Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Malignant hypertension.

E Z Rabin

    Canadian Medical Association Journal
    |April 22, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Rapid blood pressure reduction is key for malignant hypertension. While diazoxide is preferred, other drugs and intensive care unit monitoring improve patient outcomes and life expectancy.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Uptake of glucose during continuous arteriovenous hemofiltration.

    Critical care medicine·1993
    Same author

    Effectiveness and tolerability of once versus twice daily nitrendipine in the treatment of mild to moderate hypertension. The Canadian Nitrendipine Study Group.

    The Canadian journal of cardiology·1991
    Same author

    Once- vs. twice-daily nitrendipine in the treatment of mild to moderate hypertension, Canadian Nitrendipine Study Group.

    Journal of cardiovascular pharmacology·1991
    Same author

    Renal revascularization for acute anuria.

    CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·1988
    Same author

    Correlation of left ventricular hypertrophy and its regression by lisinopril with salt-induced hypertension.

    The Canadian journal of cardiology·1988
    Same author

    Can plasma catecholamine levels be a useful index of sympathetic nervous system activity?

    The Canadian journal of cardiology·1988
    Same journal

    Tularaemia; a problem in diagnosis.

    Canadian Medical Association journal·2010
    Same journal

    CONTROL of cancer.

    Canadian Medical Association journal·2010
    Same journal

    Bilateral diphtheritic external otitis treated with sulfathiazole.

    Canadian Medical Association journal·2010
    Same journal

    Hypoplastic anaemia treated with transfusions and folic acid fraction.

    Canadian Medical Association journal·2010
    Same journal

    Lauron in rheumatoid arthritis; a further report.

    Canadian Medical Association journal·2010
    Same journal

    HOW the socialist looks at national health service in England.

    Canadian Medical Association journal·2010
    See all related articles

    Area of Science:

    • Cardiology
    • Nephrology
    • Pharmacology

    Background:

    • Malignant or accelerated hypertension is a critical, life-threatening condition.
    • Complications of severe hypertension can be mitigated by prompt blood pressure reduction.

    Purpose of the Study:

    • To outline the management of malignant hypertension.
    • To discuss therapeutic agents and monitoring strategies for this condition.

    Main Methods:

    • Review of current therapeutic options for malignant hypertension.
    • Emphasis on intensive care unit (ICU) management and monitoring.

    Main Results:

    • Diazoxide is the primary therapeutic agent.
    • Alternative medications including trimethaphan, sodium nitroprusside, phenoxybenzamine, and hydralazine have specific applications.

    Related Experiment Videos

  • Intensive care unit settings facilitate optimal patient monitoring and management.

    • Conclusions:

    • Effective management of malignant hypertension involves rapid blood pressure reduction.
    • Modern antihypertensive therapies have significantly improved life expectancy, even in patients with renal insufficiency.